Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Colorcon
US Army
Express Scripts
Farmers Insurance
McKinsey
Harvard Business School
Cerilliant
Baxter

Generated: November 17, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021184

« Back to Dashboard

NDA 021184 describes TAZORAC, which is a drug marketed by Allergan and is included in two NDAs. It is available from two suppliers. Additional details are available on the TAZORAC profile page.

The generic ingredient in TAZORAC is tazarotene. There are eight drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the tazarotene profile page.
Summary for 021184
Tradename:TAZORAC
Applicant:Allergan
Ingredient:tazarotene
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 021184
Ingredient-typeRetinoids
Suppliers and Packaging for NDA: 021184
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
AVAGE tazarotene CREAM;TOPICAL 021184 NDA Allergan, Inc. 0023-9155 0023-9155-15 1 TUBE in 1 CARTON (0023-9155-15) > 3.5 g in 1 TUBE
AVAGE tazarotene CREAM;TOPICAL 021184 NDA Allergan, Inc. 0023-9155 0023-9155-30 1 TUBE in 1 CARTON (0023-9155-30) > 30 g in 1 TUBE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CREAM;TOPICALStrength0.05%
Approval Date:Sep 29, 2000TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CREAM;TOPICALStrength0.1%
Approval Date:Sep 29, 2000TE:ABRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:CREAM;TOPICALStrength0.1%
Approval Date:Sep 30, 2002TE:ABRLD:Yes

Expired US Patents for NDA 021184

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Allergan AVAGE tazarotene CREAM;TOPICAL 021184-003 Sep 30, 2002 ➤ Try a Free Trial ➤ Try a Free Trial
Allergan TAZORAC tazarotene CREAM;TOPICAL 021184-002 Sep 29, 2000 ➤ Try a Free Trial ➤ Try a Free Trial
Allergan TAZORAC tazarotene CREAM;TOPICAL 021184-001 Sep 29, 2000 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Cipla
Medtronic
UBS
Cantor Fitzgerald
McKesson
Merck
Boehringer Ingelheim
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.